Patents by Inventor Mehmet Candas

Mehmet Candas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090203049
    Abstract: Recombinant materials for the production of ? integrin protein characteristic of Manduca sexta are useful for screening pesticides for this moth.
    Type: Application
    Filed: January 20, 2009
    Publication date: August 13, 2009
    Inventors: Lee A. BULLA, Mehmet Candas
  • Patent number: 7349811
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Grant
    Filed: April 26, 2005
    Date of Patent: March 25, 2008
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Publication number: 20070219269
    Abstract: A bacterial protein which converts 2-methyl citrate to 2-methyl isocitrate is a previously unknown target for antibacterial agents. The protein of this activity is associated with mucoid bacteria and inhibitors of production or activity of this protein in combination with propionic acid mitigate the virulence of these bacteria.
    Type: Application
    Filed: February 27, 2007
    Publication date: September 20, 2007
    Inventors: Mehmet Candas, Lee Bulla
  • Patent number: 7183100
    Abstract: A bacterial protein which converts 2-methyl citrate to 2-methyl isocitrate is a previously unknown target for antibacterial agents. The protein of this activity is associated with mucoid bacteria and inhibitors of production or activity of this protein in combination with propionic acid mitigate the virulence of these bacteria.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: February 27, 2007
    Assignee: Biological Targets, Inc.
    Inventors: Mehmet Candas, Lee A. Bulla
  • Patent number: 7094554
    Abstract: A cDNA encoding a 200 kD receptor, BT-R2, from the pink boll worm, Pectinophora gossypiella, that binds specifically to a Bacillus thuringiensis toxin has been cloned, sequenced and characterized. The minimum toxin binding fragment has been identified. The BT-R2 cDNA permits the analysis of receptors in pink boll worm and other insects that affect crop growth and development, as well as, design assays for the cytotoxicity and binding affinity of potential pesticides. The clone and other methods described herein, permit the manipulation of natural and/or introduced homologous receptors and, thus, to specifically destroy organisms, tissues and/or cells of the target host.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: August 22, 2006
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Mehmet Candas
  • Publication number: 20050266524
    Abstract: Recombinant materials for the production of ? integrin protein characteristic of Manduca sexta are useful for screening pesticides for this moth.
    Type: Application
    Filed: November 29, 2004
    Publication date: December 1, 2005
    Inventors: Lee Bulla, Mehmet Candas
  • Publication number: 20050196807
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Application
    Filed: April 26, 2005
    Publication date: September 8, 2005
    Inventors: Lee Bulla, Mehmet Candas
  • Patent number: 6928368
    Abstract: The present invention provides a system, method and apparatus for targeting gene sequences having one or more phenotypic characteristics using a computer. One or more phenotypic characteristics are selected. A gene sequence is then selected that is known to have the selected phenotypic characteristics. In addition, one or more databases containing cataloged gene sequences are selected. The selected gene sequence is compared to the cataloged gene sequences, and any cataloged gene sequences that contain a portion of the selected gene sequence are extracted. The selected gene sequence is aligned to each portion of the extracted gene sequence and the extracted gene sequences are prioritized based on the alignment of the selected gene sequence. At least one of the prioritized gene sequences is selected based on one or more phenotypic criteria. Finally, one or more degenerate primers are designed to target the selected-prioritized gene sequences.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: August 9, 2005
    Assignee: The Board Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Publication number: 20040248276
    Abstract: A bacterial protein which converts 2-methyl citrate to 2-methyl isocitrate is a previously unknown target for antibacterial agents. The protein of this activity is associated with mucoid bacteria and inhibitors of production or activity of this protein in combination with propionic acid mitigate the virulence of these bacteria.
    Type: Application
    Filed: May 19, 2003
    Publication date: December 9, 2004
    Inventors: Mehmet Candas, Lee A. Bulla
  • Publication number: 20040229207
    Abstract: A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 18, 2004
    Inventors: Lee A. Bulla, Mehmet Candas
  • Patent number: 6797490
    Abstract: A composition and method for killing fire ants is disclosed that includes the purified and activated Cry toxin from a novel strain of Bacillus thuringiensis, wherein the water soluble, partially purified, activated toxin is provided along with an attractant to kill the imported fire ant using a biodegradable, environmentally sound glycoprotein without a need for toxic chemicals.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: September 28, 2004
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6759230
    Abstract: A novel microorganism producing a nontoxic, non-antigenic exopolysaccharide is taught. The exopolysaccharide has neutral sugars migrating at the same rate as mannose, fucose, fructose and galactose, acidic sugars migrating at the same rate as fucose and amine sugars migrating at the same rate as glucose and fucose, and wherein the ratio of galactose:fucose:glucose:mannose is about 1:2:3:6. The microbe and the exopolysaccharide have uses as a biofilm in geologic applications and have several consumer uses as food and drug polymers and use as a plasma extender.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: July 6, 2004
    Assignee: The Board of Regents, The University of Texas
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Publication number: 20040040059
    Abstract: A cDNA encoding a 200 kD receptor, BT-R2, from the pink boll worm, Pectinophora gossypiella, that binds specifically to a Bacillus thuringiensis toxin has been cloned, sequenced and characterized. The minimum toxin binding fragment has been identified. The BT-R2 cDNA permits the analysis of receptors in pink boll worm and other insects that affect crop growth and development, as well as, design assays for the cytotoxicity and binding affinity of potential pesticides. The clone and other methods described herein, permit the manipulation of natural and/or introduced homologous receptors and, thus, to specifically destroy organisms, tissues and/or cells of the target host.
    Type: Application
    Filed: July 18, 2003
    Publication date: February 26, 2004
    Inventors: Lee A. Bulla, Mehmet Candas
  • Patent number: 6660497
    Abstract: A cDNA encoding a 200 kD receptor, BT-R2, from the pink boll worm, Pectinophora gossypiella, that binds specifically to a Bacillus thuringiensis toxin has been cloned, sequenced and characterized. The minimum toxin binding fragment has been identified. The BT-R2 cDNA permits the analysis of receptors in pink boll worm and other insects that affect crop growth and development, as well as, design assays for the cytotoxicity and binding affinity of potential pesticides. The clone and other methods described herein, permit the manipulation of natural and/or introduced homologous receptors and, thus, to specifically destroy organisms, tissues and/or cells of the target host.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: December 9, 2003
    Assignee: The Board of Regents, The University of Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Patent number: 6551800
    Abstract: A nucleic acid derived from Bacillus thuringiensis contains a nucleotide sequence that encodes a polypeptide demonstrated to be toxic to fire ants.
    Type: Grant
    Filed: October 24, 2000
    Date of Patent: April 22, 2003
    Assignee: The Board of Regents, The University Texas System
    Inventors: Lee A. Bulla, Jr., Mehmet Candas
  • Publication number: 20030054391
    Abstract: A composition and method for killing fire ants is disclosed that includes the purified and activated Cry toxin from a novel strain of Bacillus thuringiensis, wherein the water soluble, partially purified, activated toxin is provided along with an attractant to kill the imported fire ant using a biodegradable, environmentally sound glycoprotein without a need for toxic chemicals.
    Type: Application
    Filed: August 16, 2002
    Publication date: March 20, 2003
    Inventors: Lee A. Bulla, Mehmet Candas